Insilico Medicine Opens AI Longevity Research Toolkit
Insilico Medicine introduced an open AI toolkit for aging research in a Cell cover study, the company said in a press release. The toolkit includes the LongevityBench evaluation benchmark, Longevity LLMs trained on clinical and multi omics aging data, and the Longevity Claw research agent.
The study tested 26 AI systems, including 18 frontier systems. The specialized models contain 0.6 billion to 9 billion parameters, with L-Qwen3.5-9B recording the highest overall LongevityBench score.
Longevity Claw combines the model with tools for gene set enrichment, biological aging clock calculations, population analysis, evidence synthesis and target evaluation. Across 14 hallmarks of aging, it identified 328 potential intervention targets, with enrichment of up to 5.6 fold against an independent reference set.
Insilico Medicine released the benchmark, models, training resources, evaluation code and Longevity Claw for public research use.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 17 Gates Foundation Commits $1 Billion to Expand AI Access Sep 17 Inductive Bio launches Beacon-2 to predict human drug doses Sep 17 Gigasheet Launches AI Agent for Healthcare Claim Benchmarking Sep 17 Canary Speech Joins TIME's 2026 HealthTech Ranking Sep 17 DarioHealth Wins Contract With Major New Jersey Health PlanLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
MediSights Reports Study Using AI Agents for Myeloma Market Research
Linearis Joins Two Canadian AI Health Data Projects
ADLM Calls for CLIA Rules to Cover AI in Laboratory Medicine
Apex Intelligence Raises Nearly $50 Million for Self Improving AI Models
Atman Health Wins ARPA-H Award to Build Heart Failure AI
Daily AI Brief: the AI news that matters, in your inbox.